Clean Science & Technology Ltd

Clean Science Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Clean Science & Technology Ltd

₹ 1,470 0.70%
13 Jun - close price
cleanscience.co.in BSE: 543318 NSE: CLEAN
About

Incorporated in 2003, Clean Science and Technology Ltd is one of the leading chemical manufacturers globally. It manufactures functionally critical specialty chemicals such as Performance Chemicals (MEHQ, BHA, and AP), Pharmaceutical Intermediates (Guaiacol and DCC), and FMCG Chemicals (4-MAP and Anisole). [1]

Key Points

Product Segment [1]
1) Performance Chemicals (69% in FY25 vs 69% in FY22): It manufactures Monomethyl Ether of Hydroquinone (MEHQ), used as a polymerization inhibitor in acrylic acids, acrylic esters, super absorbent polymers (diapers and sanitary pads), Butylated Hydroxy Anisole (BHA), used as anti-oxidant in food and feed industry, Ascorbyl Palmitate (AP), used in infant food formulations, breakfast cereals, and cosmetics, Tertiary Butyl Hydroquinone (TBHQ) used as a stabilizer in the oil industry and Hindered Amine light Stabilizers (HALS), used in water treatment and UV stabilization in a variety of polymers. TBHQ ranks 2nd globally, while the rest of the products are ranked no.1.

Website BSE NSE
  • Market Cap ₹ 15,618 Cr.
  • Current Price ₹ 1,470
  • High / Low ₹ 1,690 / 1,062
  • Stock P/E 53.4
  • Book Value ₹ 137
  • Dividend Yield 0.34 %
  • ROCE 29.2 %
  • ROE 21.9 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 25.2%
  • Company has been maintaining a healthy dividend payout of 20.3%

Cons

  • Stock is trading at 10.7 times its book value
  • Working capital days have increased from 116 days to 205 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE 500 Nifty 500 BSE MidCap BSE Allcap BSE Commodities

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
205 234 248 237 217 188 181 195 225 217 228 232 245
121 143 150 129 112 112 106 108 127 120 133 129 141
Operating Profit 84 91 98 108 105 77 76 86 99 98 95 102 105
OPM % 41% 39% 39% 46% 49% 41% 42% 44% 44% 45% 41% 44% 43%
7 11 3 12 12 12 5 8 13 10 10 5 12
Interest 0 0 0 0 0 0 0 0 1 0 0 0 0
Depreciation 7 8 9 9 10 11 11 11 11 11 11 11 11
Profit before tax 84 94 92 112 108 78 69 83 101 96 94 96 105
Tax % 26% 25% 26% 25% 25% 25% 25% 25% 26% 25% 28% 22% 25%
62 70 68 84 81 59 52 62 75 72 67 74 79
EPS in Rs 5.88 6.63 6.42 7.90 7.62 5.51 4.89 5.87 7.04 6.79 6.35 6.97 7.40
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
140 191 241 393 419 512 685 936 789 922
92 118 168 256 234 253 385 533 452 523
Operating Profit 48 72 73 137 186 260 300 403 338 399
OPM % 34% 38% 30% 35% 44% 51% 44% 43% 43% 43%
2 4 5 11 11 25 30 39 38 36
Interest 3 0 1 0 0 0 0 1 1 0
Depreciation 6 6 8 11 14 17 25 36 44 44
Profit before tax 41 70 70 137 182 267 305 405 331 391
Tax % 34% 33% 30% 28% 23% 26% 25% 25% 25% 25%
27 47 49 98 140 198 229 304 248 292
EPS in Rs 192.41 330.79 343.72 690.82 1,051.82 18.68 21.52 28.57 23.31 27.51
Dividend Payout % 13% 12% 12% 15% 2% 134% 15% 18% 21% 22%
Compounded Sales Growth
10 Years: %
5 Years: 17%
3 Years: 10%
TTM: 17%
Compounded Profit Growth
10 Years: %
5 Years: 16%
3 Years: 9%
TTM: 18%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -5%
1 Year: 9%
Return on Equity
10 Years: %
5 Years: 29%
3 Years: 25%
Last Year: 22%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 1 1 1 1 1 11 11 11 11 11
Reserves 99 143 186 271 341 529 758 1,008 1,205 1,446
12 0 1 3 3 0 0 1 1 1
27 35 48 53 85 120 156 139 154 147
Total Liabilities 139 179 236 328 430 660 925 1,159 1,371 1,605
64 77 101 126 166 186 296 427 401 364
CWIP 0 2 1 4 3 55 44 4 2 4
Investments 1 32 18 76 134 233 247 428 666 907
75 68 115 122 127 187 338 300 302 330
Total Assets 139 179 236 328 430 660 925 1,159 1,371 1,605

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
69 45 85 160 193 127 299 277 279
-52 -17 -94 -106 -186 -124 -245 -228 -221
-15 -5 -11 -55 -6 -0 -55 -53 -52
Net Cash Flow 2 23 -20 -1 1 4 -0 -3 6

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 68 41 60 55 61 53 82 58 75 73
Inventory Days 246 165 93 79 98 156 143 122 146 118
Days Payable 79 73 85 48 101 180 166 90 124 83
Cash Conversion Cycle 235 134 69 87 58 29 59 89 97 108
Working Capital Days 131 64 61 65 35 32 90 66 78 205
ROCE % 55% 42% 59% 59% 61% 47% 45% 30% 29%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
78.51% 78.50% 78.50% 78.50% 74.98% 74.98% 74.98% 74.98% 74.98% 74.97% 74.97% 74.96%
4.43% 4.43% 3.99% 3.99% 5.84% 6.01% 5.92% 5.88% 6.05% 5.83% 5.98% 6.07%
4.51% 4.48% 4.65% 4.76% 6.41% 5.23% 5.13% 5.04% 4.55% 4.77% 5.46% 5.77%
12.55% 12.58% 12.86% 12.74% 12.78% 13.79% 13.98% 14.11% 14.42% 14.43% 13.59% 13.21%
No. of Shareholders 2,70,4462,70,6162,75,1022,70,8232,66,9712,85,2592,78,6532,79,3952,73,8412,54,6292,46,7982,37,016

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls